Brooklyn Investment Group Acquires 906 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• BK Investment Group increased its stake in UnitedHealth Group by 15.4%, bringing its total holdings to approximately $3.55 million.
• Institutional investors now own 87.86% of UnitedHealth Group's stock, with significant investments from various hedge funds, including a notable boost of 56,142.1% in shares by GAMMA Investing LLC.
• UnitedHealth Group declared a quarterly dividend of $2.21 per share, representing a yield of 2.9%, with an upcoming payment date on September 23rd.

Brooklyn Investment Group lifted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,776 shares of the healthcare conglomerate's stock after acquiring an additional 906 shares during the quarter. UnitedHealth Group accounts for approximately 0.8% of Brooklyn Investment Group's investment portfolio, making the stock its 21st largest holding. Brooklyn Investment Group's holdings in UnitedHealth Group were worth $3,549,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC boosted its stake in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC increased its holdings in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $1,321,000. First Trust Advisors LP grew its holdings in shares of UnitedHealth Group by 28.1% in the fourth quarter. First Trust Advisors LP now owns 215,034 shares of the healthcare conglomerate's stock valued at $108,777,000 after purchasing an additional 47,174 shares during the period. Finally, Meritage Group LP grew its holdings in shares of UnitedHealth Group by 902.5% in the fourth quarter. Meritage Group LP now owns 300,755 shares of the healthcare conglomerate's stock valued at $152,140,000 after purchasing an additional 270,755 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. KeyCorp cut their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Finally, Barclays reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $365.38.

UnitedHealth Group Stock Performance

NYSE UNH traded up $4.8590 during trading hours on Thursday, reaching $304.6990. The company's stock had a trading volume of 8,357,765 shares, compared to its average volume of 12,823,508. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $275.96 billion, a PE ratio of 13.20, a PEG ratio of 1.96 and a beta of 0.43. The business has a 50-day simple moving average of $288.81 and a 200 day simple moving average of $392.90.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 EPS. The company's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.